
    
      Subjects aged 12 months of age and older and who are given study vaccine during routine
      health-care visits will be enrolled in the study.

      No study vaccine will be supplied or administered as part of this study, subjects will be
      monitored following routine vaccine administration in clinical settings.
    
  